Tisch MS News

Tisch MSRCNY and Dr. Violaine Harris have been featured in an article in Managed Healthcare Executive about the preliminary analysis of results from our FDA-approved stem cell treatment study. The Q&A highlights the impact of our stem cell research, in particular the potential of our biomarker...

July 13, 2022


Last week our researchers and physicians discussed a paper about the identification of anti-oligodendrocyte antibodies and their implications in MSdisease pathology. MSis an autoimmune disease characterized by damage to the Central Nervous System (CNS), specifically to myelin sheaths and...

July 27, 2022


Join us in congratulating Rose for her outstanding performance as the Best Junior Scientist!

August 3, 2022


The paper shows that MS patients receiving anti-CD20 therapy saw strong T-cell activation in response to receiving the COVID-19 vaccination, even in conditions of deficient antibody production. Furthermore, our research found no difference in patients’ T-cell response regardless of form of the...

August 8, 2022



Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.